These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 33583856)

  • 21. Perceptions and expectations of adults with type 1 diabetes for the use of artificial pancreas systems with and without glucagon addition: Results of an online survey.
    Taleb N; Quintal A; Rakheja R; Messier V; Legault L; Racine E; Rabasa-Lhoret R
    Nutr Metab Cardiovasc Dis; 2021 Feb; 31(2):658-665. PubMed ID: 33358714
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The artificial pancreas: current status and future prospects in the management of diabetes.
    Peyser T; Dassau E; Breton M; Skyler JS
    Ann N Y Acad Sci; 2014 Apr; 1311():102-23. PubMed ID: 24725149
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dual-hormone artificial pancreas for management of type 1 diabetes: Recent progress and future directions.
    Infante M; Baidal DA; Rickels MR; Fabbri A; Skyler JS; Alejandro R; Ricordi C
    Artif Organs; 2021 Sep; 45(9):968-986. PubMed ID: 34263961
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Efficacy of Basal Rate and Carbohydrate Ratio Learning Algorithm for Closed-Loop Insulin Delivery (Artificial Pancreas) in Youth with Type 1 Diabetes in a Diabetes Camp.
    Palisaitis E; El Fathi A; Von Oettingen JE; Krishnamoorthy P; Kearney R; Jacobs P; Rutkowski J; Legault L; Haidar A
    Diabetes Technol Ther; 2020 Mar; 22(3):185-194. PubMed ID: 31596127
    [No Abstract]   [Full Text] [Related]  

  • 25. The artificial pancreas in 2017: The year of transition from research to clinical practice.
    Kovatchev B
    Nat Rev Endocrinol; 2018 Feb; 14(2):74-76. PubMed ID: 29286043
    [No Abstract]   [Full Text] [Related]  

  • 26. Effect of artificial pancreas systems on glycaemic control in patients with type 1 diabetes: a systematic review and meta-analysis of outpatient randomised controlled trials.
    Weisman A; Bai JW; Cardinez M; Kramer CK; Perkins BA
    Lancet Diabetes Endocrinol; 2017 Jul; 5(7):501-512. PubMed ID: 28533136
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Home use of a bihormonal bionic pancreas versus insulin pump therapy in adults with type 1 diabetes: a multicentre randomised crossover trial.
    El-Khatib FH; Balliro C; Hillard MA; Magyar KL; Ekhlaspour L; Sinha M; Mondesir D; Esmaeili A; Hartigan C; Thompson MJ; Malkani S; Lock JP; Harlan DM; Clinton P; Frank E; Wilson DM; DeSalvo D; Norlander L; Ly T; Buckingham BA; Diner J; Dezube M; Young LA; Goley A; Kirkman MS; Buse JB; Zheng H; Selagamsetty RR; Damiano ER; Russell SJ
    Lancet; 2017 Jan; 389(10067):369-380. PubMed ID: 28007348
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Artificial pancreas: an emerging approach to treat Type 1 diabetes.
    Kumareswaran K; Evans ML; Hovorka R
    Expert Rev Med Devices; 2009 Jul; 6(4):401-10. PubMed ID: 19572795
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improving the Safety and Functionality of an Artificial Pancreas System for Use in Younger Children: Input from Parents and Physicians.
    Gildersleeve R; Riggs SL; Cherñavvsky DR; Breton MD; DeBoer MD
    Diabetes Technol Ther; 2017 Nov; 19(11):660-674. PubMed ID: 28854339
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nocturnal glucose control with an artificial pancreas at a diabetes camp.
    Phillip M; Battelino T; Atlas E; Kordonouri O; Bratina N; Miller S; Biester T; Stefanija MA; Muller I; Nimri R; Danne T
    N Engl J Med; 2013 Feb; 368(9):824-33. PubMed ID: 23445093
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intraperitoneal insulin delivery provides superior glycaemic regulation to subcutaneous insulin delivery in model predictive control-based fully-automated artificial pancreas in patients with type 1 diabetes: a pilot study.
    Dassau E; Renard E; Place J; Farret A; Pelletier MJ; Lee J; Huyett LM; Chakrabarty A; Doyle FJ; Zisser HC
    Diabetes Obes Metab; 2017 Dec; 19(12):1698-1705. PubMed ID: 28474383
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of dual-hormone artificial pancreas to alleviate the carbohydrate-counting burden of type 1 diabetes: A randomized crossover trial.
    Gingras V; Rabasa-Lhoret R; Messier V; Ladouceur M; Legault L; Haidar A
    Diabetes Metab; 2016 Feb; 42(1):47-54. PubMed ID: 26072052
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Novel Dual-Hormone Insulin-and-Pramlintide Artificial Pancreas for Type 1 Diabetes: A Randomized Controlled Crossover Trial.
    Haidar A; Tsoukas MA; Bernier-Twardy S; Yale JF; Rutkowski J; Bossy A; Pytka E; El Fathi A; Strauss N; Legault L
    Diabetes Care; 2020 Mar; 43(3):597-606. PubMed ID: 31974099
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 'We're all on the same team'. Perspectives on the future of artificial pancreas systems by adults in Australia with type 1 diabetes using open-source technologies: A qualitative study.
    Schipp J; Skinner TC; Holloway E; Scibilia R; Langstrup H; Speight J; Hendrieckx C
    Diabet Med; 2022 May; 39(5):e14708. PubMed ID: 34599617
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of an artificial pancreas at diabetes camps.
    Arch Dis Child; 2013 Jul; 98(7):514. PubMed ID: 23905186
    [No Abstract]   [Full Text] [Related]  

  • 36. [Technological innovations in the treatment of type 1 diabetes in pediatrics].
    Tubiana-Rufi N
    Soins Pediatr Pueric; 2016; (288):38-40. PubMed ID: 26776695
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Automatic data processing to achieve a safe telemedical artificial pancreas.
    Hernando ME; García-Sáez G; Martínez-Sarriegui I; Rodríguez-Herrero A; Pérez-Gandía C; Rigla M; de Leiva A; Capel I; Pons B; Gómez EJ
    J Diabetes Sci Technol; 2009 Sep; 3(5):1039-46. PubMed ID: 20144417
    [TBL] [Abstract][Full Text] [Related]  

  • 38. DIY artificial pancreas: A narrative of the first patient and the physicians' experiences from India.
    Kesavadev J; Saboo B; Kar P; Sethi J
    Diabetes Metab Syndr; 2021; 15(2):615-620. PubMed ID: 33725629
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outpatient glycemic control with a bionic pancreas in type 1 diabetes.
    Russell SJ; El-Khatib FH; Sinha M; Magyar KL; McKeon K; Goergen LG; Balliro C; Hillard MA; Nathan DM; Damiano ER
    N Engl J Med; 2014 Jul; 371(4):313-325. PubMed ID: 24931572
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MiniMed 670G hybrid closed loop artificial pancreas system for the treatment of type 1 diabetes mellitus: overview of its safety and efficacy.
    Saunders A; Messer LH; Forlenza GP
    Expert Rev Med Devices; 2019 Oct; 16(10):845-853. PubMed ID: 31540557
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.